BXCL-701 advances into phase II portion of phase Ib/II trial with pembrolizumab for tNEPC April 28, 2020
Enrollment open in phase I/IIa study of PBCAR-269A in relapsed/refractory multiple myeloma April 28, 2020
European Commission approves Fetcroja for infections due to aerobic Gram-negative bacteria April 28, 2020
RSS